Keywords: Human
telomerase reverse transcriptase, pontin, reptin, dyskerin, telomerase, cancer
Cochran, "Signal transducer and activator of transcription 3 (STAT3) regulates human
telomerase reverse transcriptase (hTERT) expression in human cancer and primary cells," Cancer Research, vol.
Significance of immunological detection of human
telomerase reverse transcriptase. Am J Pathol.
has granted a non-exclusive license to Procter & Gamble relating to Geron's human
telomerase reverse transcriptase (hTERT) technology for cell research applications.
The tie-up will see this "immortalisation" process extended by using Geron's human
telomerase reverse transcriptase (hTERT) technology to keep the cells alive for longer and make them a closer match to those living cells inside the body.
[2] Nonstandard abbreviations: CTCs, circulating tumor cells; ALDH, aldehyde dehydrogenase; EpCAM, epithelial cell adhesion molecule; MET, mesenchymal-epithelial transition; NSCLC, non-small cell lung cancer; TERT,
telomerase reverse transcriptase.
reported that strongly repressed human
telomerase reverse transcriptase expression decreased telomerase activity and remarkably shortened telomeres by demethylation following 5-aza-dC treatment.
Molecular mechanisms involved in endothelial cell aging: role of
telomerase reverse transcriptase. Z Gerontol Geriatr.
METHODS: We measured LTL, as well as mRNA expression and promoter DNA methylation of the telomerase catalytic enzyme gene [human
telomerase reverse transcriptase (bTERT)] in blood samples obtained from 63 steel workers on the first day of a workweek (baseline) and after 3 days of work (postexposure).
Mitochondrial
telomerase reverse transcriptase binds to and protects mitochondrial DNA and function from damage.
Mutations in one of 8 genes involved in telomere biology--DKC1, TINF2, TERC, TERT (
telomerase reverse transcriptase), NHP2 [NHP2 ribonucleoprotein homolog (yeast)], NOP10 [NOP10 ribonucleoprotein homolog (yeast)], WRAP53 (WD repeat containing, antisense to TP53; formerly TCAB1), and CTC1 (CTS telomere maintenance complex component 1)--can be identified in approximately 50% of patients with clinical features of classic DC, the remainder being as yet uncharacterized (3, 4).